...
首页> 外文期刊>Toxicology: An International Journal Concerned with the Effects of Chemicals on Living Systems >Protein tyrosine phosphatase 1B (PTP1B): A key regulator and therapeutic target in liver diseases
【24h】

Protein tyrosine phosphatase 1B (PTP1B): A key regulator and therapeutic target in liver diseases

机译:蛋白酪氨酸磷酸酶1B(PTP1B):肝脏疾病的关键调节剂和治疗靶标

获取原文
获取原文并翻译 | 示例
           

摘要

Phosphorylation of tyrosine residues within proteins, which is controlled by the reciprocal action of protein tyrosine kinases and protein tyrosine phosphatases, plays a key role in regulating almost all physiological responses. Therefore, it comes as no surprise that once the balance of tyrosine phosphorylation is disturbed, drastic effects can occur. Protein tyrosine phosphatase 1B (PTP1B), a classical non-transmembrane tyrosine phosphatase, is a pivotal regulator and promising drug target in type 2 diabetes and obesity. Recently it has received renewed attention in liver diseases and represents an intriguing opportunity as a drug target by modulating hepatocyte death and survival, hepatic lipogenesis and so on. Here, the multiple roles of PTP1B in liver diseases will be presented, with respect to liver regeneration, drug-induced liver disease, non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
机译:蛋白质内酪氨酸残基的磷酸化受蛋白质酪氨酸激酶和蛋白质酪氨酸磷酸酶的相互作用控制,在调节几乎所有生理反应中起关键作用。因此,酪氨酸磷酸化的平衡一旦受到干扰,就会发生剧烈的作用,这也就不足为奇了。蛋白质酪氨酸磷酸酶1B(PTP1B)是一种经典的非跨膜酪氨酸磷酸酶,是2型糖尿病和肥胖症的关键调节剂和有希望的药物靶标。近来,它在肝脏疾病中受到了新的关注,并且通过调节肝细胞的死亡和存活,肝脂肪形成等,成为了作为药物靶标的有趣机会。在这里,将介绍PTP1B在肝脏疾病中的多种作用,涉及肝脏再生,药物性肝病,非酒精性脂肪肝疾病(NAFLD)和肝细胞癌。 (C)2015 Elsevier Ireland Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号